Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

NCT01098734 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
148
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Welichem Biotech Inc.